Our Model
Not Your Typical Pharma Company
Building New Pharma
By combining efficient therapeutic development with unique payer and health system partnerships, we are working to create a model that generates substantial cost savings—savings that are reflected in the price of our medicines.
We are re-engineering how we create, develop, and deliver innovative medicines. We're rethinking partnerships throughout the healthcare ecosystem, creating a new business model to address the burden of high prices.
We're working to achieve lower costs by:
- Reducing costly R&D failure by focusing on established classes within known science
- Utilising the latest technology and system partnerships to create greater levels of efficiency
- Minimising the need for large sales teams and advertising budgets
Motivated by the substantial cost savings this new category represents over time, health systems and payers are partnering with us to design this model.
Our Partnerships
Built on aligned incentives, we're developing an inclusive alliance of partnerships with health systems and payers.
The primary objective is to create a better, more equitable experience for patients receiving the medicines they need. Examples of the types of partners we're working with include:
- single-payer systems
- regional payers
- national payers
- integrated delivery networks
Motivated by the potential savings our new medicines represent, these partners are collaborating with us to drive greater access to these new products within their respective systems. We’re building relationships all over the world, with a focus on Europe for our initial launches.
Together we can create New Pharma.
Patent-Protected, New Medicines
Learn about our
10+ therapy
candidates
Our PipelineSee what we are developing in oncology
and immunology